103 related articles for article (PubMed ID: 33830464)
1. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
Berdugo J; Rooper LM; Chiosea SI
Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
[TBL] [Abstract][Full Text] [Related]
2. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.
Lewis JS; Thorstad WL; Chernock RD; Haughey BH; Yip JH; Zhang Q; El-Mofty SK
Am J Surg Pathol; 2010 Aug; 34(8):1088-96. PubMed ID: 20588174
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of p16 for Determining HPV Status of Head and Neck Carcinomas Arising in HPV Hotspots.
Bhardwaj S; Gitman M; Ramirez JD; Paniz-Mondolfi A; Westra WH
Am J Surg Pathol; 2024 May; 48(5):581-587. PubMed ID: 38482860
[TBL] [Abstract][Full Text] [Related]
5. Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
Schulte JJ; Steinmetz J; Furtado LV; Husain AN; Lingen MW; Cipriani NA
Head Neck Pathol; 2020 Dec; 14(4):966-973. PubMed ID: 32350806
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.
Pannone G; Rodolico V; Santoro A; Lo Muzio L; Franco R; Botti G; Aquino G; Pedicillo MC; Cagiano S; Campisi G; Rubini C; Papagerakis S; De Rosa G; Tornesello ML; Buonaguro FM; Staibano S; Bufo P
Infect Agent Cancer; 2012 Feb; 7():4. PubMed ID: 22376902
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of high-risk HPV DNA PCR, p16
Simoens C; Gheit T; Ridder R; Gorbaslieva I; Holzinger D; Lucas E; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M;
BMC Infect Dis; 2022 Aug; 22(1):676. PubMed ID: 35933382
[TBL] [Abstract][Full Text] [Related]
8. Tissue Fixation Conditions for p16 Immunohistochemistry and Human Papillomavirus RNA In Situ Hybridization in Oropharyngeal Squamous Cell Carcinoma.
Lewis JS; Barnett SB; Mannion K; Mehrad M
Head Neck Pathol; 2020 Sep; 14(3):637-644. PubMed ID: 31628584
[TBL] [Abstract][Full Text] [Related]
9. Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV.
Zito Marino F; Ronchi A; Stilo M; Cozzolino I; La Mantia E; Colacurci N; Colella G; Franco R
Infect Agent Cancer; 2020; 15():46. PubMed ID: 32684947
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract][Full Text] [Related]
11. Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.
Mehanna H; Franklin N; Compton N; Robinson M; Powell N; Biswas-Baldwin N; Paleri V; Hartley A; Fresco L; Al-Booz H; Junor E; El-Hariry I; Roberts S; Harrington K; Ang KK; Dunn J; Woodman C
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1863-9. PubMed ID: 26749143
[TBL] [Abstract][Full Text] [Related]
12. Relevance of Partial p16 Immunostaining in Oral Squamous Cell Carcinoma and Co- Relation with HPV DNA Status.
Naz F; Tanveer N; Verma H; Sudheer KA; Kakkar A; Ranjan A; Chopra A; Tanwar P
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4093-4096. PubMed ID: 38156842
[TBL] [Abstract][Full Text] [Related]
13. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
Head Neck; 2024 Apr; ():. PubMed ID: 38594829
[TBL] [Abstract][Full Text] [Related]
14. Expression of human papillomavirus-related proteins and its clinical implication in tonsillar squamous cell carcinoma.
Song JS; Kim MS; Park JW; Lee YS; Kang CS
Korean J Pathol; 2012 Apr; 46(2):177-86. PubMed ID: 23109998
[TBL] [Abstract][Full Text] [Related]
15. Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
Grønhøj C; Jensen DH; Dehlendorff C; Marklund L; Wagner S; Mehanna H; Munck-Wikland E; Ramqvist T; Näsman A; Wittekindt C; Würdemann N; Sharma SJ; Gattenlöhner S; Kiss K; Andersen E; Spruce R; Batis N; Robinson M; Harrington K; Winter S; Jones TM; Klussmann JP; Dalianis T; Friborg J; von Buchwald C
Br J Cancer; 2018 Jun; 118(12):1672-1681. PubMed ID: 29795309
[TBL] [Abstract][Full Text] [Related]
16. Advances in testing for human papillomavirus -mediated head and neck cancer.
Mehanna H; Alemany L; von Buchwald C
Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of the HPV status site-specific factor 10 (SSF-10) variable for patients with oropharyngeal cancers in the Iowa Cancer Registry, 2010-2014.
Kahl AR; Charlton ME; Pagedar NA; Sperry SM; Matt B; Platz C; Lynch CF
Head Neck; 2018 Oct; 40(10):2199-2209. PubMed ID: 29934978
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach.
Craig SG; Anderson LA; Schache AG; Moran M; Graham L; Currie K; Rooney K; Robinson M; Upile NS; Brooker R; Mesri M; Bingham V; McQuaid S; Jones T; McCance DJ; Salto-Tellez M; McDade SS; James JA
Br J Cancer; 2019 Apr; 120(8):827-833. PubMed ID: 30890775
[TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma.
Sathasivam HP; Santambrogio A; Andoniadou CL; Robinson M; Thavaraj S
Ann Oncol; 2018 Oct; 29(10):2144-2145. PubMed ID: 30101315
[No Abstract] [Full Text] [Related]
20. Hpv impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil.
Buexm LA; Soares-Lima SC; Brennan P; Fernandes PV; de Souza Almeida Lopes M; Nascimento de Carvalho F; Santos IC; Dias LF; de Queiroz Chaves Lourenço S; Ribeiro Pinto LF
Cancer Lett; 2020 May; 477():70-75. PubMed ID: 32087309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
